EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300

Susu Guo iD, Xiaodi Hu, Jennifer L Cotton iD, Lifang Ma, Qi Li, Jiangtao Cui, Yongjie Wang, Ritesh P Thakare, Zhipeng Tao, Y Tony Ip iD, Xu Wu, Jiayi Wang iD und 1 weitere

eLife · 2025

DOI: 10.7554/elife.98386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Susu Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Oncogene Proteins, Fusion, Carcinogenesis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Natural Science Foundation of China, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies on Hippo pathway regulation of tumorigenesis largely center on YAP and TAZ, the transcriptional co-regulators of TEADs. Here, we present an oncogenic mechanism involving VGLL and TEAD fusions that is Hippo pathway-related but YAP/TAZ-independent. We characterize two recurrent fusions, VGLL2-NCOA2 and TEAD1-NCOA2 , recently identified in human spindle cell rhabdomyosarcoma. We demonstrate that in contrast to VGLL2 and TEAD1 the fusion proteins are potent activators of TEAD-dependent transcription, and the function of these fusion proteins does not require YAP/TAZ. Furthermore, we identify that VGLL2 and TEAD1 fusions engage specific epigenetic regulation by recruiting histone acetyltransferase EP300 to control TEAD-mediated transcriptional and epigenetic landscapes. We show that small-molecule EP300 inhibition can suppress fusion protein-induced oncogenic transformation both in vitro and in vivo in mouse models. Overall, our study reveals a molecular basis for VGLL involvement in cancer and provides a framework for targeting tumors carrying VGLL , TEAD , or NCOA translocations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDNA-Binding ProteinsOncogene Proteins, FusionCarcinogenesisE1A-Associated p300 ProteinSarcomaAdaptor Proteins, Signal TransducingNuclear ProteinsHumansTEA Domain Transcription FactorsAnimalsMiceYAP-Signaling ProteinsNuclear Receptor Coactivator 2

Stichwörter der Autor:innen

EP300HIPPONCOA2TEADVGLL2YAPcancer biologydevelopmental biologyhuman

Substanzen

Transcription FactorsTEA Domain Transcription FactorsTEAD1 protein, humanDNA-Binding ProteinsOncogene Proteins, FusionEP300 protein, humanE1A-Associated p300 ProteinYAP-Signaling ProteinsYAP1 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, United States.
  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, United States.
  • Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.

ORCID-Profile: Susu Guo, Jennifer L Cotton, Y Tony Ip, Jiayi Wang, Junhao Mao

Förderung

  • NIDDK NIH HHS
  • National Natural Science Foundation of China
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R. P., Tao, Z., Ip, Y. T., Wu, X., Wang, J., & Mao, J. (2025). VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. https://doi.org/10.7554/elife.98386

Vancouver

Guo S, Hu X, Cotton JL, Ma L, Li Q, Cui J, et al. VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300. eLife. 2025. doi:10.7554/elife.98386

BibTeX
@article{Guo2025,
  author = {Guo, Susu and Hu, Xiaodi and Cotton, Jennifer L and Ma, Lifang and Li, Qi and Cui, Jiangtao and Wang, Yongjie and Thakare, Ritesh P and Tao, Zhipeng and Ip, Y Tony and Wu, Xu and Wang, Jiayi and Mao, Junhao},
  title = {VGLL2 and TEAD1 fusion proteins identified in human sarcoma drive YAP/TAZ-independent tumorigenesis by engaging EP300},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.98386}
}
Kostenlos starten →